Harold A. Deas, also known as Art, has been the Chief Executive Officer of Acella Pharmaceuticals, LLC, since February 3, 2016, and served as its Chief Operating Officer until February 3, 2016.
Art has more than 25 years of pharmaceutical experience, initiating his pharmaceutical career with Marion Laboratories. Since then, he served as Vice President of Marketing and Sales at Alliant Pharmaceuticals, Inc. He has also served positions of progressive leadership and responsibility within the pharmaceutical and biotech industry including: sales, institutional sales, marketing, clinical research, professional education, new product marketing, district manager, regional manager, and division sales manager for companies such as Genentech and Aventis.
The significant contributions Art has made throughout his career in the pharmaceutical industry provide the necessary framework for future growth and sustainability. He has been instrumental in helping Acella build a successful portfolio of generic and specialty niche pharmaceutical drug and medical device products. Art continuously drives expansion while identifying strategic opportunities within the markets that are essential to the company’s business.
He holds a Bachelor of Science in Biology from the University of South Carolina and an MBA in International Business from The Edinburgh Business School.